chrisvoncsefalvay/vaers-outcomes huggingface dataset:
has seen people with some rashes with the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of RASH (has seen people with some rashes with the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (has seen people with some rashes with the second dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (has seen people with some rashes with the second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Extreme fatigue; achy muscles; chills; 102 degree fever; inflammation under left arm pit; sore joints; headache; injection site pain; general sick feeling.
She was administered Hepatitis A Vaccine by mistake since she corresponded to the kinrix vaccine (DTAP and POLIO). At the moment the child did not present any side effects, mom states the child only presents a little Hyperthermia but did not require medication.
massive hard lump at injection site; warm to touch; massive hard lump at injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (massive hard lump at injection site), VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE INDURATION (massive hard lump at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (massive hard lump at injection site), VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE INDURATION (massive hard lump at injection site). At the time of the report, VACCINATION SITE MASS (massive hard lump at injection site), VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE INDURATION (massive hard lump at injection site) outcome was unknown. Not Provided     I got my second shot on 23 May and have a massive hard lump at injection site, no redness, but warm to touch  Consent for follow-up unknown.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Followup
When my daughter was born she had nothing wrong with her and when she got her first baby shots in her left leg her left leg got swollen. I talked to the dr. about and he said the swelling will go down; just put a ice pack on, Time past on and every time she got her shot they gave it to her in the same leg and I keep asking why haven't the swelling went down. He said it was baby fat. No treatment what so ever he thought she had hip click which that diagnosis was wrong. I decided to go to a different hospital to a second oppion on my daughter leg because it was not getting better I took her the hospital. They told me she had hemihypertophy and hyper pigmentation and slightly enlarge liver. I went back and they are still running more test on her but they still denied that her problem has anything do with ber baby shots but like I said from the beginning she was a perfect baby when she was born and I look at each part of her body and I did not notice nothing wrong with her and I still belive that swollen to her left leg and her left body has something to do with her baby shots!
Mother reports increase temp to 103.9 F, vomiting at 24 hrs. post receiving vaccinations.
Pt reported to health unit this Am 11/5/07, reported severe itching to injection site day of injection 10/29/07, site had spot band aid applied post removal on 10/31/07, site became red and raised then skin rash spread all over body, hives and irreg pattern rash to bilat armpits/groin area severely itchy, denied any resp sxs, Rx Aveeno baths, instructed to see PMD today for eval/tx'mt.
first shot of Engerix-B one year ago/her second shot on the 19th July, 2021; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 41-year-old female patient who received HBV (Engerix B) (batch number 74EM4, expiry date 20th December 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (1st dose of Engerix B one year ago in 2020).   On 19th July 2021, the patient received the 2nd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On 19th July 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: This case was reported by the pharmacy intern. The patient received her second shot on the 19th July 2021, later than the recommended interval, which led to lengthening of the vaccine schedule. The patient did not specify the exact day or lot number because the patient was vaccinated in another facility. No further events were reported at the time of reporting. The reporter consented to follow up.
Cellulitis right lateral thigh at injection site of VARIVAX. Treated KEFLEX today. Expect it should resolve.
upon administering the vaccine the needle malfunctioned and it is unsure how much was given. it was decided with permission of the patient and guidance from my district manager and patient care coordinator to re administer the dose.
Patient had SHINGRIX vaccine administered on 7/10/2019, this was second shot. She had typical reaction of redness to injection are and localized swelling. On 7/11 she had 2 episodes of tightness in her chest almost as if it was exercise induced asthma. First episode was after she had played tennis and then again that evening when she was trying to sleep. Patient then went to local ER where they attributed the tightness from a reaction from the SHINGRIX. The patient did not a reaction from the first dose, lot 53rf3 s/n 5wcfcogn5v.
1. 4 days after this Moderna dose,  onset of L occipital neuralgia, which continues.  2. An approximate 15 min episode of atrial fibrillation,  identified with Kardia mobile app
This case was reported by a consumer and described the occurrence of fever in a male patient who received PEDIARIX. On an unknown date, the patient received PEDIARIX at an unknown dose. On an unknown date, an unknown time after receiving PEDIARIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to PEDIARIX. Additional information received: The consumer mentioned that her son, the patient, experienced a fever after being vaccinated with PEDIARIX.
This spontaneous report as received from a certified medical assistant refers to an patient of unknown age and gender. On an unknown date in 2014 (also reported as since 24-JUN-2014), was vaccinated with (Oka/Merck) VARIVAX, subcutaneous (lot # K002927 expiration date not reported), dose and route not reported which went out of temperature range multiple times. These excursions were supported. No adverse effects were reported. Outcome of the events were not reported. Causality was not reported. This case has been linked to 1408USA009333, 1408USA013366, and 1408USA013367 as same reporter link. Additional information has been requested.
Started feeling tired, voice got hoarse, arm turned red, swelling, and hot, then got infected got worse as time went on given antibiotics for infection. Still have bump where shot was given. AUGMENTIN 875-125 10 day 2 times a day. Cellulitis & maybe viral pharyngitis.
Pt recvd 3 doses of Engerix-B & did not respond; recvd 2 booster doses of Engerix-B; titer results pending;
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 4-month-old female patient who received KINRIX. Concomitant products included Rotavirus vaccine. On 16th February 2018, the patient received KINRIX (intramuscular). On 16th February 2018, less than a day after receiving KINRIX, the patient experienced injection site pain and inappropriate age at vaccine administration. On an unknown date, the outcome of the injection site pain and inappropriate age at vaccine administration were unknown. It was unknown if the reporter considered the injection site pain to be related to KINRIX. Additional details were provided as follows: A 4 month old patient received an injection of KINRIX on leg, which led to inappropriate age at vaccine administration. The patient also received an unspecified rotavirus oral vaccine and other unspecified routine vaccinations on the same date.
Itchiness at injection site redness. Patient treating with BENADRYL cream. Is getting better.
INJECTION SITE SORENESS; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's past medical history included: surgery for ovarian cancer, and concurrent conditions included: non-alcoholic, non-smoker, and ovarian cancer, and other pre-existing medical conditions included: No known drug allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: 23-AUG-2021) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On MAR-2021, treatment medications included: paracetamol.  On 15-MAR-2021, the patient experienced injection site soreness. The action taken with covid-19 vaccine  was not applicable. The patient recovered from injection site soreness on 17-MAR-2021. This report was non-serious.
Redness, swelling, itching 40 minute intense itching and then went down hand, finally subsided, still hard, painful and 2 inch lump and hot to touch.
Symptom onset 12/9/22. Treatment includes: Admission, Paxlovid, IV therapy.
My daughter complained of not feeling well after being administered the vaccination. She then fainted and had convulsions. After feeling better for ten minutes she felt ringing in ears, nausea, and felt faint again. Waited one hour to leave office.
HAS BEEN SICK FOR 2  WEEKS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced has been sick for 2 weeks. The action taken with covid-19 vaccine was not applicable. The outcome of has been sick for 2 weeks was not reported. This report was non-serious.
Left arm hurts really bad, shoulder, elbow forearm very bad pain, fingers tingle, baby finger still numb. Seen Neurologist, got MRI of neck & left shoulder, pain & anti-inflammatory medicine.  MRI doctor said no nerve damage but I still have pain and will get an EMG on Dec. 1, 2010. I got a flu shot last year but not N1H1 because my age group didn't need it & had no bad reaction.  This year the N1H1 was already in the flu vaccine so I can't know for sure why I'm in such pain in only my left arm? Today I asked the Neurologist if the numbness would leave my finger and he said it should get better but its been three weeks since this started and 5 weeks since I received the flu vaccine. I just thought I'd report this just-in-case it's related.
Swollen foot; This spontaneous case was reported by an other health care professional and describes the occurrence of PERIPHERAL SWELLING (Swollen foot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (Swollen foot). At the time of the report, PERIPHERAL SWELLING (Swollen foot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the patient received the booster on a Thursday and had a swollen foot the next morning. Patient think it was gout, but the patient was not sure.  No concomitant medication were given. No treatment information were provided.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 80-year-old female patient received bnt162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". Additional information: All of her previous 4 Covid vaccines and boosters, the last one in Jun2023, have been from Pfizer and the most she got from them was a sore arm.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Information has been received from a physician concerning a patient who was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccine included measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). The reporter was not sure if the patient had varicella virus vaccine live measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) on the same day. It was reported that the patient developed a macular rash on their trunk and torso and had a fever of 103F two weeks after receiving varicella virus vaccine live and measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). It was noted that the reporter felt that the rash did not appear to be a varicella like rash. Follow up information from a physician indicated that the child had viral type not due to varicella virus vaccine live. Follow up information from a physician indicated that the child had viral type not due to varicella virus vaccine live. Follow up information from a physician indicated that the event was not a vaccine allergy and the patient had no reactions. Additional information is not expected.
Fever of 100.4, unable to sleep, body aches, weakness, tiredness.
No adverse effect; a patient was administered a dose of VARIVAX that was improperly stored; This spontaneous report as received from a nurse prescriber refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On 07-MAY-2019 the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # R019235, expiry date: 04-JUL-2019) subcutaneously for prophylaxis.  The varicella virus vaccine live (oka/merck)(VARIVAX) was stored in temperature of 44.4 degree Fahrenheit (F) for 1 hour. There was no previous temperature excursion reported. A digital data logger was involved. No adverse effects were reported. No product quality complaint was involved.
Patient is a 89 y.o. female with a PMHx of HTN, CHF, Afib, who presented to the emergency department for evaluation of cough that started approximately 2-3 weeks ago.  She currently does not have complaints except for coughing, decreased appetite. Per ED documentation, she had also complained of shortness of breath. Of note, patient was seen in this ED on 8/18/2021 due to fluid retention after being noncompliant with her furosemide. She was restarted on her diuretic and was discharged. Daughter noticed that patient has since developed a wet cough and decided to bring the patient to the ED on 8/26/2021.  Rapid COVID test positive, oxygen saturation was 90% on room air so patient was started on 2L of oxygen.   She was also started on remdesivir and dexamethasone.  Patient's oxygen saturation rapidly improved and she was discharged from hospital the next day with an Rx for dexamethasone x 8 days.   Patient reported she has been vaccinated. She received her second shot in late February.
Patient reported she began to feel bad on her way home after receiving the vaccine (she had waited at the clinic for 15 minutes after receiving the vaccine and felt fine at the clinic).  She reported she began to have a rapid heart rate (which went away that evening) and elevated blood pressure. She normally takes a BP med and took an extra 1/2 pill that evening. Her BP was up to 178/101 and came down to 124/78. She reports she is still not feeling well (but BP is within her normal range). She reports she will contact her PCP. I advised her to go to the urgent care and she wants to wait to see her PCP.  She agrees to go to urgent care or ER if condition worsens.
Two cases of shingles: one on top of another.  I am now having a third outbreak.
pt recv vax & mom reports pt went home & was alittle cranky;mom reports that PM pt was walking  & turned around & fell flat on back;negative LOC, no movement of extremities;hit head hard on ground & was pale;pt taken to ER but didn't wait;
THE PATIENT REPORTED THAT 3 DAYS AFTER SHE RECEIVED THE VACCINE, THAT SHE EXPERIENCED A FEVER IN HER ARM AND REDNESS THAT WENT ALL THE WAY ALMOST TO HER ELBOW.  SHE SAYS THAT AT THE TIME SHE COULD NOT EVEN IDENTIFY THE INJECTION SITE AT THE TIME OF INJECTION BUT AFTER THE FEVER STARTED THAT A LITTLE KNOT FORMED OVER THE INJECTION SITE. THIS LASTED A FEW DAYS AND THEN THE SYMPTOMS WENT AWAY.  SHE REPORTED THIS WHEN SHE SHOWED UP TO RECEIVE ANOTHER VACCINATION OF A DIFFERENT NATURE A FEW MONTHS LATER.
Fever, tachycardia, hives on face, generalized body aches and pain, swelling and lymphadenopathy at and around injection site
Quarter sized lump spread the diameter of 3 quarters together, red. Tx: TYLENOL, ice/cool compress.
Soreness of the left arm that started a few days after the vaccine.  No issues right after the vaccine.  Then about one week after the vaccine, patient experience pain the arm and she cannot move the arm too high.  Will see the MD on 12-31-19 but will try to see the MD sooner.
36 weeks pregnant. Vomiting started at 10am the day after receiving both vaccinations. Managed symptoms at home. Mild muscle soreness at injection site and low grade fever (controlled with tylenol).   Cannot remember if this is 5th or 6th dose of covid shot. It is the booster after receiving the bivalent booster last spring.
This spontaneous report was received from a pharmacist referring to a 63 year old female patient. The patient's historical drugs included Lisinopril (manufacturer unknown) 10 mg, omeprazole 20 mg capsules and pravastatin 20 mg. The patient had no concomitant medications or drug reactions or allergies. Concurrent conditions were not reported. On 07-FEB-2017, the patient was vaccinated with ZOSTAVAX (lot # M035693, expiration date: 07-NOV-2017) (dose, frequency and route of administration were unspecified) for prophylaxis. On 08-FEB-2017, the patient called the pharmacist  to report that she experienced an injection site reaction, about 2 inches by 1 inch oval slightly elevated, reddened and bruised. The pharmacist reported that otherwise the patient was fine, that she sought for medical attention and received unspecified treatment for these adverse events. At the time of the report, the outcome of injection site inflammation, vaccination site bruising and vaccination site erythema was reported as recovering. No causality relatedness was specified. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), LETHARGY (lethargy), DEPRESSION (depression), DEPRESSED MOOD (feeling sad and heavy) and HEAD DISCOMFORT (heavy feeling in my head) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced CHILLS (chills and got worse and worse). On 07-Feb-2021, the patient experienced PAIN (body aches), FATIGUE (tired) and HEADACHE (crushing headache). On an unknown date, the patient experienced LETHARGY (lethargy), DEPRESSION (depression), DEPRESSED MOOD (feeling sad and heavy), HEAD DISCOMFORT (heavy feeling in my head), CHEST DISCOMFORT (heavy feeling in my chest) and NAUSEA (mild nausea). On 08-Feb-2021, HEADACHE (crushing headache) had resolved. At the time of the report, PAIN (body aches), LETHARGY (lethargy), DEPRESSION (depression), DEPRESSED MOOD (feeling sad and heavy), HEAD DISCOMFORT (heavy feeling in my head), CHEST DISCOMFORT (heavy feeling in my chest), NAUSEA (mild nausea), FATIGUE (tired) and CHILLS (chills and got worse and worse) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, Body temperature: 101 (High) 101.   Action taken with mRNA-1273 was not applicable     No concomitant medications reported by reporter. Treatment medication not reported.   This case was linked to MOD-2021-052028 (E2B Linked Report).; Sender's Comments:  MOD-2021-052028:first dose
normal body aches/body pain is getting worse pretty quickly; difficulty breathing; a lot of mucus and congestion in his chest.; a lot of mucus and congestion in his chest.; coughing a lot; This is a spontaneous report from a Pfizer sponsored program via a contactable consumer. A 28-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient experienced normal body aches, difficulty breathing, coughing a lot, body pain was getting worse pretty quickly. He did not have a temperature, but hard time breathing, a lot of mucus and congestion in his chest. Outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.